Transcriptomic markers of biological aging in breast cancer survivors: a longitudinal study
JNCI: Journal of the National Cancer Institute · 01.02.2025 · 117 (2) · 312-321
DOI: 10.1093/jnci/djae201 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 08.10.2024. Verfasst von Judith E Carroll und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles (UCLA), Los Ange…. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer Survivors, Aging, Transcriptome. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH, NCI.
Abstract (Originalsprache)
Background
The purpose of this study was to examine the impact of breast cancer therapy on biological aging as measured by expression of genes for cellular senescence (p16INK4a, SenMayo), DNA damage response, and proinflammatory senescence-associated secretory phenotype.
Methods
This longitudinal, observational study evaluated women diagnosed with breast cancer (stage 0-III) prior to radiation therapy (RT) and/or chemotherapy (CT) and at repeated visits out to 2 years. Peripheral blood mononuclear cell gene expression was assessed using RNA sequencing on quality-verified RNA. Longitudinal data were analyzed using mixed linear models and a zero-inflated 2-part model.
Results
Women (mean age = 55.5 years) receiving CT with or without RT (n = 73) had higher odds (odds ratio = 2.97, 95% confidence interval = 1.52 to 5.8) of having detectable p16INK4a following treatment compared with RT (n = 76) or surgery alone (n = 37). The proportion of women expressing 16INK4a over the follow-up period increased in all treatment groups (P < .001), with no interaction by treatment. All groups also increased over time in DNA damage response (P < .001), SenMayo (P < .001), and senescence-associated secretory phenotype (P < .001). Groups differed in the pattern of increase over time with statistically significant quadratic time by group differences for CT with or without RT compared with RT alone for DNA damage response (P = .05), SenMayo (P = .006), and the senescence-associated secretory phenotype (P = .02).
Conclusions
Results revealed activation of genes associated with biological aging in women with breast cancer from diagnosis through early survivorship, including DNA damage response, cell senescence, and the inflammatory secretome. Increases were evident across cancer treatments, although women receiving CT showed sustained increases, whereas RT exhibited slowing at later time points. Overall, findings suggest that women treated for breast cancer are aging within their immune cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
- Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.
- Department of Biostatistics, UCLA Fielding School of Public Health, Los Angeles, CA, USA.
- Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
- Department of Health Policy and Management, UCLA Fielding School of Public Health, Los Angeles, CA, USA.
ORCID-Profile: Judith E Carroll, Laura Petersen, Julienne E Bower
Förderung
- NCI NIH HHS
- NIH
- NCI
- National Cancer Institute
Zitieren
APA
Carroll, J. E., Crespi, C. M., Cole, S., Ganz, P. A., Petersen, L., & Bower, J. E. (2025). Transcriptomic markers of biological aging in breast cancer survivors: a longitudinal study. JNCI: Journal of the National Cancer Institute, 117(2), 312-321. https://doi.org/10.1093/jnci/djae201
Vancouver
Carroll JE, Crespi CM, Cole S, Ganz PA, Petersen L, Bower JE. Transcriptomic markers of biological aging in breast cancer survivors: a longitudinal study. JNCI: Journal of the National Cancer Institute. 2025;117(2):312-321. doi:10.1093/jnci/djae201
BibTeX
@article{Carroll2025,
author = {Carroll, Judith E and Crespi, Catherine M and Cole, Steve and Ganz, Patricia A and Petersen, Laura and Bower, Julienne E},
title = {Transcriptomic markers of biological aging in breast cancer survivors: a longitudinal study},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
volume = {117},
number = {2},
pages = {312--321},
doi = {10.1093/jnci/djae201}
}
EUVIMED